RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, announced it...
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...
Certis Oncology Solutions (Certis), a translational science and precision oncology company, announced it has been selected as "Overall Immunology Company of the Year" in...
ArisGlobal , developer of the LifeSphere ® technology platform and a leader in global patient treatment solutions, has announced impressive new study results demonstrating the effectiveness of Proactive Safety...
Investment supported by additional financing from a strong syndicate of new and existing institutional investors, along with industry leaders
Terray Therapeutics, a biotechnology company integrating...
Hyro's customers can now benefit from integrated conversational AI to improve the patient journey, reduce agent burnout, and leverage data to optimize operations
Hyro announced it...
Osmo, a machine olfaction startup, announced the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to advance the company's AI-enabled scent...
XSOLIS, the artificial intelligence (AI) technology company creating a more efficient healthcare system, announced that it has been recognized on the 2023 Deloitte Technology...
Alimentiv Inc., AcelaBio Inc. and PharmaNest Inc. announce a collaboration to provide precision medicine and artificial intelligence (AI)-powered digital pathology solutions for metabolic dysfunction-associated...
bit.bio, the company coding human cells for novel cures, announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to...